STEAP2 and prostate cancer: Specifically, Korkmaz et al. (2002) revealed that STEAP2 is highly expressed in androgen-sensitive, androgen receptor-positive prostate cancer cells, but not in androgen receptor-negative prostate cancer cells, suggesting that the regulation of STEAP2 expression may be related to sex hormone signaling.